Expand chart
Adapted from CivicScience; Chart: Axios Visuals

A recent poll of more than 1,200 adults who plan to buy toys this holiday found that almost half of those purchases will be made at online-only retailers like Amazon.

By the numbers: A little more than 40% of respondents said their shopping will be done inside stores, either at a big box retailer like Target and Walmart or at a specialty toy store.

Watch this space: "American toy shoppers who have a Prime membership are over 200% more likely to make the bulk of their toy purchases online compared to Amazon subscribers who don’t have a Prime membership. They are also 125% more likely to buy mostly online compared to people who don’t have an Amazon account at all," data firm CivicScience found.

  • "On the flip side, Amazon.com account holders who don’t have a Prime membership are 150% more likely to use Target.com or Walmart.com for the bulk of their toy purchases."

Go deeper: The decline of Black Friday

Go deeper

Updated 58 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Politics: Chris Christie: Wear a mask "or you may regret it — as I did" — Senate Democrats block vote on McConnell's targeted relief bill.
  2. Business: New state unemployment filings fall.
  3. Economy: Why the stimulus delay isn't a crisis (yet).
  4. Health: FDA approves Gilead's remdesivir as a coronavirus treatment How the pandemic might endMany U.S. deaths were avoidable.
  5. Education: Boston and Chicago send students back home for online learning.
  6. World: Spain and France exceed 1 million cases.

FBI: Russian hacking group stole data after targeting local governments

FBI Headquarters. Photo: Mark Wilson/Getty Images

Energetic Bear, a Russian state-sponsored hacking group, has stolen data from two servers after targeting state and federal government networks in the U.S. since at least September, the FBI and Cybersecurity and Infrastructure Security Agency said on Thursday.

Driving the news: Director of National Intelligence John Ratcliffe announced Wednesday that Iran and Russia had obtained voter registration information that could be used to undermine confidence in the U.S. election system.

FDA approves Gilead's remdesivir as a coronavirus treatment

A production line of Remdesivir. Photo: Fadel Dawood/picture alliance via Getty Images

Gilead Sciences on Thursday received approval from the Food and Drug Administration for remdesivir, an antiviral treatment that has shown modest results against treating COVID-19.

Why it matters: It's the first and only fully FDA-approved drug in the U.S. for treating the coronavirus.